type 2 diabetes mellitus
Conditions
Interventions
None listed
Sponsors
Toho University Omori Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria are included in this study; 1. Patients with type 2 diabetes mellitus 2. Patients who used Ozempic at least once till 2022/6/30 3. Patients aged 18 years or older at the initiation of this study (at approval by institutional review board)
Exclusion criteria
Exclusion criteria: Patients who fall into any of the following criteria are excluded from participating in the study; 1. Patients with type 1 diabetes mellitus 2. Patients with excessive drinking of alcohol (net alcohol intake is more than 60g/day for male or 30g/day for female) 3. Patients with dementia 4. Patients who were pregnant during data collection period 5. Patients who were hospitalized for a week or longer within 52 weeks after the initial date 6. Patients with poor medication adherence (judged by attending physician) 7. Patients with other conditions that the attending physician think inappropriate to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in HbA1c | — |
Secondary
| Measure | Time frame |
|---|---|
| Change or percent change in the following items; - Major blood tests - Other general blood tests - vital signs | — |
Countries
Japan
Contacts
Public ContactArata Yoneda
EviPRO Co., Ltd. EviPRO Co., Ltd.
Outcome results
None listed